Investigators employed cell sheets engineered from clinical-grade human clonal bone marrow-derived mesenchymal stem cells and transplanted these onto intact renal capsule to evaluate their therapeutic ability in the rat ischemia reperfusion injury model.
[Tissue Engineering Part C-Methods]